Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression

The use of nutraceuticals during cancer treatment is a long-lasting debate. Berberine (BBR) is an isoquinoline quaternary alkaloid extracted from a variety of medicinal plants. BBR has been shown to have therapeutic effects in different pathologies, particularly in cancer, where it affects pathways...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oxidative medicine and cellular longevity 2020, Vol.2020 (2020), p.1-11
Hauptverfasser:	Favre, Claudio, Bruno, Gennaro, Subbiani, Angela, Calvani, Maura
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - chemistry Adrenergic beta-Antagonists - pharmacology Adrenergic beta-Antagonists - therapeutic use Adrenergic receptors Animals Apoptosis Berberine - chemistry Berberine - therapeutic use Bone marrow Brain Neoplasms - drug therapy Brain Neoplasms - pathology Cancer Cancer therapies Cardiovascular disease Care and treatment Catecholamines Cell Proliferation - drug effects Chemotherapy Development and progression Dietary Supplements Disease Progression Drug therapy FDA approval Growth Health aspects Heart failure Humans Kinases Medical prognosis Medicine, Botanic Medicine, Herbal Melanoma Metabolites Metastasis Mirabegron Mutation Nebivolol Neuroblastoma Neuroblastoma - drug therapy Neuroblastoma - pathology Ovarian cancer Prostate Proteins Review Tumors Vincristine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!